Real-world experience with trifluridine/tipiracil on metastatic colorectal cancer in a third level hospital

被引：0
|
作者：
Rosero Rodriguez, D. [1 ]
Perez de Aguado, P. [2 ]
Chamorro Perez, J. [1 ]
Albarran Fernandez, V. [2 ]
Longo, F. [3 ]
Reguera Puertas, P. [4 ]
Delfrade, M. [4 ]
Fuentes Mateos, R. [2 ]
Guillen-Ponce, C.
Lopez Gomez, V. [2 ]
Rodriguez Garrote, M. [4 ]
Vaz, M. [1 ]
Villamayor Delgado, M. [1 ]
Fernandez Fradejas, J. [2 ]
Garrido, P. [2 ]
Gil, M. [1 ]
Pozas, J. [3 ]
Gemeno Lopez, E. [2 ]
Sotoca Rubio, P. [2 ]
Alia Navarro, V. [2 ]
Barrill Corpa, A. [4 ]
Ferreiro Monteagudo, R. [3 ]
机构：
[1] Inst Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal, Serv Oncol Med, Madrid, Spain
[2] Hosp Univ Ramon & Cajal, Madrid, Spain
[3] Inst Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal, Madrid, Spain
[4] Hosp Univ Ramon & Cajal, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-192
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [21] Real-world impact of KRAS mutations on clinical outcomes in metastatic colorectal cancer treated with trifluridine-tipiracil in the USA
    Labadie, Brian William
    Birch, Cierra
    Quayle, Carol
    Lou, Emil
    Algaze, Sandra
    Xiu, Joanne
    Park, Soo J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
    Arrichiello, Gianluca
    Perrone, Alessandra
    Napolitano, Stefania
    Martini, Giulia
    De Falco, Vincenzo
    Incoronato, Pasquale
    Laterza, Maria Maddalena
    Facchini, Gaetano
    Famiglietti, Vincenzo
    Nacca, Valeria
    Paragliola, Fernando
    Napolitano, Rossella
    Suarato, Gabriella
    Nicastro, Antonella
    Martinelli, Erika
    Ciardiello, Davide
    Ciardiello, Fortunato
    Troiani, Teresa
    TARGETED ONCOLOGY, 2022, 17 (06) : 635 - 642
  • [23] Real-world efficacy and safety of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies
    Martinez Lago, N.
    Alonso de Castro, B.
    Varela Ponte, R.
    Reboredo Rendo, C.
    Gomez-Randulfe Rodriguez, M.
    Grana Suarez, B.
    de la Camara Gomez, J.
    Mateos Salvador, M.
    Busto Fernandez, F.
    Calleja Chucla, T.
    Reboredo-Lopez, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S106 - S107
  • [24] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Celeste B. Burness
    Sean T. Duggan
    Drugs, 2016, 76 : 1393 - 1402
  • [25] Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study
    Signorelli, Carlo
    Calegari, Maria Alessandra
    Basso, Michele
    Anghelone, Annunziato
    Lucchetti, Jessica
    Minelli, Alessandro
    Angotti, Lorenzo
    Zurlo, Ina Valeria
    Schirripa, Marta
    Chilelli, Mario Giovanni
    Morelli, Cristina
    Dell'Aquila, Emanuela
    Cosimati, Antonella
    Gemma, Donatello
    Ribelli, Marta
    Emiliani, Alessandra
    Corsi, Domenico Cristiano
    Arrivi, Giulia
    Mazzuca, Federica
    Zoratto, Federica
    Morandi, Maria Grazia
    Santamaria, Fiorenza
    Saltarelli, Rosa
    Ruggeri, Enzo Maria
    CURRENT ONCOLOGY, 2023, 30 (06) : 5456 - 5469
  • [26] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Burness, Celeste B.
    Duggan, Sean T.
    DRUGS, 2016, 76 (14) : 1393 - 1402
  • [27] Metastatic Colorectal Cancer Management with trifluridine/tipiracil
    White, Teresa
    Larson, Heidi
    Minnella, Alexandra
    Hochster, Howard S.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : E30 - E37
  • [28] Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib
    Patel, Anuj K.
    Duh, Mei S.
    Barghout, Victoria
    Yenikomshian, Mihran A.
    Xiao, Yongling
    Wynant, Willy
    Tabesh, Majid
    Fuchs, Charles S.
    CLINICAL COLORECTAL CANCER, 2018, 17 (03) : E531 - E539
  • [29] Trifluridine/Tipiracil (TAS-102) in refractory metastatic colorectal cancer: Real-world data of 13 oncological centers in Portugal
    Tomas, T.
    Nogueira-Costa, G.
    Eriz, I.
    Vitorino, M.
    Baptista, M. Vaz
    Correia, M.
    Pereira, T.
    Oliveira, A.
    Leal da Costa, L.
    Pimenta, J.
    Liu, P.
    Peixeto, I.
    Luz, P.
    Gil, L.
    Silva, D.
    Caleca, T.
    Neves, M.
    Quintela, A.
    Monteiro, A.
    Atalaia, G.
    Silva, M.
    Fiuza, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 88 - 88
  • [30] An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study
    Nie, Caiyun
    Xu, Weifeng
    Chen, Beibei
    Lv, Huifang
    Wang, Jianzheng
    Liu, Yingjun
    He, Yunduan
    Wang, Saiqi
    Zhao, Jing
    Chen, Xiaobing
    CLINICAL COLORECTAL CANCER, 2023, 22 (01) : 76 - 84
12345